What Is Pelvic Floor Surgery and Who Needs It?

Discover insights into pelvic floor surgery: what it is, why it’s considered, and the path to recovery for better pelvic health.

Pelvic floor surgery is a broad category of operations that repair or reinforce the muscles, ligaments, and connective tissue forming the hammock-like structure at the base of the pelvis. These procedures treat conditions like organ prolapse (when pelvic organs slip out of position), urinary incontinence, and fecal incontinence. The people who need pelvic floor surgery are overwhelmingly those whose symptoms have not improved with physical therapy, pessary devices, or other nonsurgical approaches, and the specific operation depends on which structures have failed and how severely. While it is far more common in women, men also undergo pelvic floor procedures, most often after prostate surgery.

The Conditions Behind the Surgery

Your pelvic floor does a deceptively large amount of work. It holds the bladder, uterus (in women), and rectum in place, and it helps control when you urinate and have bowel movements. When the muscles or connective tissue weaken, one or more of those organs can descend, and the control systems that keep you continent can break down. Weakness of the levator ani muscle and enlargement of the gap it spans put excessive tension on the surrounding tissue, leading to breaks and thinning in the support system. The result can be pelvic organ prolapse, where you feel a bulge or heaviness in the vagina, or various forms of incontinence.

Urinary incontinence comes in two main forms. Stress incontinence involves leaking urine when you cough, sneeze, or exercise. Urgency incontinence involves a sudden, overwhelming need to urinate with leaking before you reach a bathroom. Many people have a mix of both. The underlying causes overlap and can include dysfunction of the bladder muscle itself, weak pelvic floor muscles, and disrupted nerve signaling that controls storage and voiding. Fecal incontinence, though less discussed, is another pelvic floor disorder that sometimes requires surgical correction when sphincter damage is involved.

Who Is Most at Risk

Vaginal childbirth is the biggest contributor to pelvic floor disorders in women. Traumatic deliveries, forceps use, a prolonged second stage of labor, and sphincter damage during birth are all recognized risk factors. Maternal age, the baby’s position, and the baby’s head size also play a role but are not controllable. Despite the clear association between vaginal delivery and pelvic floor damage, the evidence does not support recommending elective cesarean section purely to prevent these problems.

Menopause is another major independent risk factor, particularly for fecal incontinence. One study found that menopause increased the odds of fecal incontinence nearly sixfold, while a history of complicated deliveries involving instruments or breech presentation roughly quadrupled those odds. Chronic straining from constipation, obesity, heavy lifting, chronic cough, and connective tissue disorders can also weaken the pelvic floor over time. The upshot is that pelvic floor disorders become more common as women age, and the accumulation of risk factors over a lifetime means many women will face some degree of these problems.

How Doctors Assess Severity

Before anyone discusses surgery, clinicians need to gauge how far the prolapse has progressed or how severe the incontinence is. The most widely used tool for prolapse is the Pelvic Organ Prolapse Quantification system, often called POP-Q. It measures six specific points along the vaginal wall relative to the hymenal ring, then assigns a stage. A prolapse reaching close to that ring is generally considered at least stage two and is usually symptomatic. The system also records the length of the perineal body and the total vaginal length to create a complete picture.

POP-Q has become the go-to staging system internationally because it offers a level of detail that older classification methods could not match. Imaging like pelvic floor ultrasound can be added to correlate with clinical findings. In one study, two independent urogynecologists performing POP-Q staging achieved strong agreement, which reassures patients that the staging is reproducible and not just one clinician’s judgment call. For incontinence, assessment typically involves a detailed history, bladder diaries, and sometimes urodynamic testing to distinguish between stress and urgency types.

When Surgery Becomes the Right Option

Surgery is not the first thing doctors reach for. Pelvic floor physical therapy, lifestyle changes like weight loss and fluid management, and pessary devices (silicone supports inserted into the vagina to hold organs in place) are all tried first. Research has shown that both pessaries and surgery produce meaningful symptom relief: prospective studies have found similar improvements in urinary and bowel symptoms, sexual function, and quality of life for both approaches.

That said, surgery does hold an edge in some outcomes. A large multicenter study found that after two years, about 84% of women who had surgery reported subjective improvement compared with roughly 74% in the pessary group. Both groups had meaningful reductions in bothersome symptoms, so the difference is real but not enormous. Surgery typically comes into the conversation when a pessary does not stay in place or is uncomfortable, when symptoms are severe enough to disrupt daily life, or when the patient simply prefers a more definitive fix after trying conservative options.

Types of Prolapse Surgery

The specific operation depends on which part of the pelvic floor has given way. When the top of the vagina (the “apex”) has descended, sacrocolpopexy is considered the gold standard. This procedure attaches mesh to the vaginal vault and anchors it to the sacrum, essentially re-suspending the vagina from the spine. It can be done through an open abdominal incision, through traditional laparoscopy, or with robotic assistance. A systematic review and meta-analysis pooling data on nearly 1,500 robotic-assisted sacrocolpopexy procedures found objective cure rates ranging from 84% to 100% and subjective cure rates from 92% to 95%. Robotic sacrocolpopexy appears to produce outcomes comparable to open surgery while offering less blood loss and shorter hospital stays.

Not every prolapse repair requires mesh or even requires reaching the abdominal cavity. “Native tissue” repairs use your own tissue to rebuild support. For example, one laparoscopic technique fixes the vaginal stump to the round ligaments on both sides after hysterectomy, and medium-term follow-up showed no recurrence at 12 months. Traditional vaginal repairs, where the surgeon works through the vaginal opening to tighten the weakened tissue, remain widely performed and avoid the need for abdominal incisions altogether.

Surgery for Urinary Incontinence

For stress urinary incontinence that has not responded to physical therapy or behavioral strategies, the most extensively studied surgical treatment is the mid-urethral sling. A synthetic tape is placed under the urethra to provide support during moments of physical strain. These slings can be passed through the tissues behind the pubic bone (retropubic) or through the inner thigh area (transobturator). A Cochrane review, the highest standard of evidence synthesis, found that both routes produce similar short-term subjective cure rates, with the transobturator route ranging from about 62% to 98% and the retropubic route from about 71% to 97%. Slings have a good safety profile and accumulating evidence supports their effectiveness over the long term as well.

For urgency incontinence that resists medication and behavioral therapy, sacral neuromodulation is an option. This involves implanting a small device near the sacral nerves that modulates the nerve signals controlling bladder function, somewhat like a pacemaker for the bladder. In a five-year follow-up study of 60 women, the success rate was 87% at one month but gradually decreased to 62% at five years, with complete continence persisting in about 15% of patients. These numbers are reasonable given that the patients receiving neuromodulation are those for whom everything else has already failed.

Surgery for Fecal Incontinence and Rectal Prolapse

When the rectum prolapses through the anus, rectopexy, a procedure that secures the rectum to the sacrum, is generally the approach. One study found rectopexy completely controlled rectal prolapse in all treated cases, and among the patients who also had fecal incontinence alongside prolapse, only 20% remained incontinent after the rectopexy alone. When fecal incontinence persists despite resolving prolapse, additional repairs like postanal repair or sphincter reconstruction come into play. Sphincter repair controlled incontinence in about two-thirds of patients who needed it. These are less commonly discussed pelvic floor surgeries, but for the patients affected, they can be life-changing.

The Mesh Controversy

Surgical mesh deserves its own discussion because it has been one of the most contentious issues in pelvic floor surgery over the past two decades. Mesh placed through the vagina to reinforce prolapse repairs was introduced in the United States in 2005 without clinical safety and efficacy data. In the years that followed, reports of complications climbed, prompting multiple FDA warnings and eventually a market withdrawal order for transvaginal mesh for prolapse in 2019.

The evidence tells a nuanced story. A major Cochrane review found that transvaginal mesh repair did reduce prolapse recurrence and the likelihood of a woman still being aware of her prolapse afterward. Recurrent prolapse on examination dropped from about 38% after native tissue repair to roughly 11–20% after mesh repair. However, mesh also came with higher rates of new-onset stress incontinence, bladder injury, and the need for additional surgery to deal with mesh exposure, which affected about 8% of women. When all reoperations were counted together, including those for mesh complications, women in the mesh group were more likely to need another operation overall.

A five-year randomized trial comparing mesh and native tissue found that mesh performed better for anterior (front wall) prolapse, but native tissue was actually better for posterior and apical prolapse. Complications were higher in the mesh group, while recurrence was higher in the native tissue group. And for women undergoing repeat surgery for recurrent prolapse, a randomized trial found that long-term composite success rates were essentially identical at about 53–54% for both mesh and native tissue. Mesh exposure occurred in 42% of the mesh group, and the pattern of failure differed: mesh patients tended to develop prolapse in untreated compartments, while native tissue patients recurred in the compartments that had been repaired.

The practical takeaway is that mesh placed abdominally during sacrocolpopexy remains well-established and is still widely used with good outcomes. It is transvaginal mesh for prolapse that drew the FDA’s action. Mid-urethral slings, which also use synthetic mesh but in a very different configuration and location, remain a standard treatment for stress incontinence and were not subject to the same withdrawal.

When Men Need Pelvic Floor Surgery

Pelvic floor surgery is often framed as a women’s health issue, but men face their own version, most commonly after radical prostatectomy for prostate cancer. Post-prostatectomy incontinence is a well-recognized complication, and while pelvic floor exercises are the first line of treatment, many men continue to leak and eventually need surgical options.

The gold standard surgical treatment for post-prostatectomy incontinence is the artificial urinary sphincter, a device with a cuff placed around the urethra, a pressure-regulating balloon, and a small pump implanted in the scrotum. It works well, but it requires good hand dexterity to operate and carries a notable reoperation rate. For men with milder incontinence, especially those who have not had radiation therapy, male slings offer a less invasive alternative. Bulking agents, which work well for female stress incontinence, are not currently recommended for men. Regardless of which approach is used, honest counseling about the degree of continence that can realistically be restored is important, because complete dryness is not always achievable.

Surgery in Older and Frail Patients

Advanced age and frailty do not automatically rule out pelvic floor surgery, but they do change the conversation about which procedure makes sense. For frail, elderly women with advanced prolapse who are no longer sexually active, obliterative procedures such as colpocleisis, which essentially closes the vaginal canal, offer a simpler operation with less surgical stress. A recent study compared colpocleisis performed alone versus with a vaginal hysterectomy added. Both were well tolerated, but adding the hysterectomy led to more pain on the first postoperative day, greater use of painkillers, and a longer hospital stay. The patients who had colpocleisis alone were on average older and had more heart disease, yet their recovery was smoother. For patients whose primary goal is symptom relief rather than preserving vaginal function, this trade-off can make a lot of sense.

Recovery and Sexual Function

One of the biggest concerns patients raise before pelvic floor surgery is how it will affect their sex life. The evidence here is largely reassuring. A systematic review found that sexual function improves or stays the same after all types of reconstructive prolapse surgery, and total dyspareunia (pain during intercourse) decreased after every surgery type studied. New-onset dyspareunia was uncommon, ranging from 0% to 9%.

A prospective study tracking patients for two years after vaginal prolapse surgery found meaningful improvements in both quality of life and sexual function. Pain during intercourse decreased from 25% before surgery to 16% afterward, and body image scores improved as well. New-onset pain did occur in about 5% of women at one year and 10% at two years, so it is not zero risk. Separate research confirmed that global sexual function improved after both incontinence and prolapse surgery, and that the improvement in sexual function correlated with improvement in overall quality of life.

An estimated 31–44% of women with symptomatic prolapse or incontinence experience sexual dysfunction beforehand. Menopausal status was the only demographic factor that independently influenced sexual quality of life, with premenopausal women scoring better both before and after surgery, though all age groups saw improvement.

Disparities in Who Gets Which Surgery

Access to pelvic floor surgery is not equal. A systematic review of health-care disparities found that Black women were less likely to receive mesh-augmented procedures and less likely to receive reconstructive prolapse repair compared to obliterative procedures. Hispanic women and women from rural areas had decreased access to apical suspension during prolapse surgery. Older women and those on Medicare faced higher overall complication rates, and living outside the northeastern United States was associated with increased complications as well.

The barriers are not just surgical. A survey study found that Black patients lived in more disadvantaged neighborhoods and were nearly five times as likely to report multiple barriers to accessing urogynecologic care. Higher neighborhood disadvantage was independently associated with longer travel times and seeing more providers before getting a referral to a specialist. It was also associated with a lack of awareness that urogynecology even exists as a specialty. These gaps matter because the type of surgery you receive can affect your long-term outcomes, and being steered toward simpler procedures when you might benefit from a more complex one is a real equity issue.

Emerging Approaches

Researchers are exploring stem cell therapy as a potential future treatment for pelvic floor disorders. Early studies using different types of autologous stem cells (cells harvested from the patient’s own body) have shown promise in improving pelvic ligament and muscle regeneration, restoring tissue elasticity and strength, and reducing inflammatory reactions and foreign body responses compared to synthetic materials. This work is still in relatively early stages and has not reached routine clinical use, but it represents a fundamentally different strategy: rather than mechanically propping up weakened tissue or replacing it with mesh, the goal is to regenerate the tissue itself. If the approach matures, it could eventually change how mild to moderate pelvic floor disorders are managed before surgery is even considered.